These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 22923714

  • 1. Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration.
    Yang L, Krefting I, Gorovets A, Marzella L, Kaiser J, Boucher R, Rieves D.
    Radiology; 2012 Oct; 265(1):248-53. PubMed ID: 22923714
    [Abstract] [Full Text] [Related]

  • 2. Nephrogenic systemic fibrosis.
    Weinreb JC, Kuo PH.
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
    Abu-Alfa AK.
    Adv Chronic Kidney Dis; 2011 May; 18(3):188-98. PubMed ID: 21531325
    [Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis and management of high-risk patients.
    Altun E, Semelka RC, Cakit C.
    Acad Radiol; 2009 Jul; 16(7):897-905. PubMed ID: 19375360
    [Abstract] [Full Text] [Related]

  • 5. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
    Thomsen HS.
    Radiol Clin North Am; 2009 Sep; 47(5):871-5, vii. PubMed ID: 19744601
    [Abstract] [Full Text] [Related]

  • 6. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
    Weinreb JC, Abu-Alfa AK.
    J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?
    Martin DR.
    Am J Kidney Dis; 2010 Sep; 56(3):427-30. PubMed ID: 20728788
    [No Abstract] [Full Text] [Related]

  • 8. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium-based contrast agents and NSF: evidence from animal experience.
    Sieber MA, Steger-Hartmann T, Lengsfeld P, Pietsch H.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1268-76. PubMed ID: 19938039
    [Abstract] [Full Text] [Related]

  • 10. Application of extracellular gadolinium-based MRI contrast agents and the risk of nephrogenic systemic fibrosis.
    Heverhagen JT, Krombach GA, Gizewski E.
    Rofo; 2014 Jul 01; 186(7):661-9. PubMed ID: 24477507
    [Abstract] [Full Text] [Related]

  • 11. Current status of nephrogenic systemic fibrosis.
    Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H.
    Clin Radiol; 2014 Jul 01; 69(7):661-8. PubMed ID: 24582176
    [Abstract] [Full Text] [Related]

  • 12. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
    Gupta A, Shamseddin MK, Khaira A.
    Clin Exp Dermatol; 2011 Oct 01; 36(7):763-8. PubMed ID: 21790732
    [Abstract] [Full Text] [Related]

  • 13. MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety.
    Juluru K, Vogel-Claussen J, Macura KJ, Kamel IR, Steever A, Bluemke DA.
    Radiographics; 2009 Oct 01; 29(1):9-22. PubMed ID: 19019996
    [Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
    Altun E, Martin DR, Wertman R, Lugo-Somolinos A, Fuller ER, Semelka RC.
    Radiology; 2009 Dec 01; 253(3):689-96. PubMed ID: 19789233
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.
    Heinz-Peer G, Neruda A, Watschinger B, Vychytil A, Geusau A, Haumer M, Weber M.
    Eur J Radiol; 2010 Oct 01; 76(1):129-34. PubMed ID: 19619969
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
    Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.
    Radiographics; 2009 Oct 01; 29(6):1565-74. PubMed ID: 19959508
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.